Research

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under 18s

Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine’s performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA).

Domestic violence against women: giving friends and relatives the keys to help

Today [Friday 8 March] International Women's Day [IWD 2019] is celebrating the social, economic, cultural and political achievements of women but worldwide, domestic violence and abuse (DVA) is still experienced by almost one in three women. It has become a major public health issue, with profound physical and mental health impact. A research project by the University of Bristol, funded by AXA Research Fund, aims to develop resources that will help informal groups, such as friends and family, support women who experience domestic violence.